Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching Lung Lai

Showing results (61-70 of 288) with videos related to

Pageof 29
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2013
Reply to Liao et alWai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Expert Review of Gastroenterology & Hepatology|January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistanceSze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
The American Journal of Gastroenterology|May 5, 2011
The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6Wai-Kay Seto, Yasuhito Tanaka, Kevin Liu, et al.
World Journal of Gastroenterology|January 1, 2014
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infectionTao Lu, Wai-Kay Seto, Ran-Xu Zhu, et al.
Transplantation|February 18, 2003
Prophylaxis and treatment of recurrent hepatitis B after liver transplantationChung-Mau Lo, Sheung-Tat Fan, Chi-Leung Liu, et al.
Journal of Hepatology|May 26, 2004
Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversionAnnie Pang, Man-Fung Yuen, He-Jun Yuan, et al.
Clinical and Translational Gastroenterology|September 1, 2017
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015Ka-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Journal of Clinical Gastroenterology|August 23, 2002
Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinomaMan-Fung Yuen, Charmaine Hon, Chee-Kin Hui, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidKa-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Pageof 29

Showing results (61-70 of 288) with videos related to

Sort By:
Pageof 29
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
An update on the toxicological considerations for protease inhibitors used for hepatitis C infectionLung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2013
Reply to Liao et alWai-Kay Seto, Danny Ka-Ho Wong, Ching-Lung Lai, et al.
Expert Review of Gastroenterology & Hepatology|January 23, 2016
Hepatitis B: treatment choice and monitoring for response and resistanceSze-Hang Kevin Liu, Wai-Kay Seto, Ching-Lung Lai, et al.
The American Journal of Gastroenterology|May 5, 2011
The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6Wai-Kay Seto, Yasuhito Tanaka, Kevin Liu, et al.
World Journal of Gastroenterology|January 1, 2014
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infectionTao Lu, Wai-Kay Seto, Ran-Xu Zhu, et al.
Transplantation|February 18, 2003
Prophylaxis and treatment of recurrent hepatitis B after liver transplantationChung-Mau Lo, Sheung-Tat Fan, Chi-Leung Liu, et al.
Journal of Hepatology|May 26, 2004
Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversionAnnie Pang, Man-Fung Yuen, He-Jun Yuan, et al.
Clinical and Translational Gastroenterology|September 1, 2017
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015Ka-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Journal of Clinical Gastroenterology|August 23, 2002
Recombinant interferon alfa 2b therapy in a patient with metastatic hepatocellular carcinomaMan-Fung Yuen, Charmaine Hon, Chee-Kin Hui, et al.
Clinical and Translational Gastroenterology|June 23, 2017
Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidKa-Shing Cheung, Wai-Kay Seto, James Fung, et al.
Pageof 29